| Literature DB >> 22304903 |
Peter B O'Sullivan1, Darren J Beales, Anne J Smith, Leon M Straker.
Abstract
BACKGROUND: Prevalence of low back pain (LBP) rises rapidly during adolescence, reaching adult levels by the age of 18. It has been suggested that adolescent LBP is benign with minimal impact, despite limited evidence.Entities:
Mesh:
Year: 2012 PMID: 22304903 PMCID: PMC3313872 DOI: 10.1186/1471-2458-12-100
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Questions related to the prevalence and impact of low back pain
| Prevalence Questions: | |
|---|---|
| P1 | Has your low back been painful at any time in the last month? |
| P2 | Has your low back pain ever lasted for more than 3 months off and on (it hurt at |
| P3 | Has your low back pain ever lasted for more than 3 months continuously (it hurt |
| P4 | Has your midback been painful at any time in the last month? |
| P5 | Has your neck/shoulder been painful at any time in the last month? |
| I1 | Have you ever sought health professional advice or treatment for low back pain? |
| I2 | Have you ever taken medication to relieve the low back pain? |
| I3 | Have you ever missed school or work due to the low back pain? |
| I4 | Has the low back pain ever interfered with your normal activities? |
| I5 | Has the low back pain ever interfered with recreational physical activities (eg |
Differences in LBP group proportions (n(%)) overall and by gender, presence of other spinal pain areas and specific LBP impacts
| No LBP | Current Non-chronic LBP | Current chronic LBP | ||
|---|---|---|---|---|
| 873 (67.8) | 158 (12.3) | 257 (19.9) | ||
| Males (n = 610) | 474 (77.7) | 54 (8.9) | 82 (13.4) | < 0.001 |
| Females (n = 678) | 399 (58.9) | 104 (15.3) | 175 (25.8) | |
| No MBP or NSP (n = 736) | 604 (82.1) | 70 (9.5) | 62 (8.4) | < 0.001 |
| MBP or NSP (n = 368) | 198 (53.8) | 63 (17.1) | 107 (29.1) | |
| MBP and NSP (n = 178) | 67 (37.6) | 25 (14.0) | 86 (48.3) | |
| Sought health professional care (n = 156 of 415, 37.6%) | - | 30 (19.2) | 126 (80.7) | 0.007 |
| Took medication | - | 42 (29.2) | 102 (70.8) | < 0.001 |
| Missed school/work (n = 88 of 414, 21.3%) | - | 14 (15.9) | 74 (84.1) | < 0.001 |
| Interfered with normal activities | - | 30 (18.8) | 130 (81.2) | < 0.001 |
| Interfered with physical activities | - | 43 (24.0) | 136 (76.0) | < 0.001 |
| 0 (n = 139 of 412, 33.7%)) | - | 82 (59.0) | 57 (41.0) | < 0.001 |
| 1 (n = 78, 18.9%) | - | 32 (41.0) | 46 (59.0) | |
| 2 (n = 58, 14.1%) | - | 18 (31.0) | 40 (69.0) | |
| 3 (n = 55, 13.4%) | - | 10 (18.2) | 45 (81.8) | |
| 4 (n = 42, 10.2%) | - | 9 (21.4) | 33 (78.6) | |
| 5 (n = 40, 9.7%) | - | 5 (12.5) | 35 (87.5) | |
SF36 Physical and Mental Component Summary Scores (Mean(SD)) by LBP group, gender and other spinal pain areas
| PCS | MCS | |||
|---|---|---|---|---|
| No LBP | 53.2 (6.4) | < 0.001 | 51.8 (7.9) | < 0.001 |
| Current Non-chronic LBP | 50.3 (6.9)a | 48.5 (9.2) a | ||
| Current chronic LBP | 47.4 (9.0)a, b | 45.8 (10.1) a, b | ||
| Male | 53.6 (6.0) | < 0.001 | 52.7 (7.4) | < 0.001 |
| Female | 50.0 (8.1) | 48.0 (9.5) | ||
| No MBP or NSP | 53.8 (6.0) | < 0.001 | 52.3 (7.8) | < 0.001 |
| MBP or NSP | 49.7 (8.1)c | 48.2 (9.6) c | ||
| MBP and NSP | 47.1 (8.1)c, d | 45.6 (9.0) c, d | ||
a statistically significant contrast to No LBP
b statistically significant contrast to Current Non-chronic LBP
c statistically significant contrast to No Mid Back Pain or Neck/Shoulder Pain
d statistically significant contrast to MBP or NSP
Regression Coefficients1 for General Linear Model for SF36 Physical and Mental Component Summary Scores (n = 1242)
| Physical Component Summary Scores | ||
|---|---|---|
| No LBP | REF | |
| Current Non-chronic LBP | ||
| Males | -2.16 (-4.09,-0.23) | 0.028 |
| Females | -1.39 (-2.85, 0.07) | 0.062 |
| Current chronic LBP | ||
| Males | -1.28 (-2.93,0.36) | 0.127 |
| Females | -4.60 (-5.88,-3.32) | < 0.001 |
| No LBP | ||
| Males | REF | |
| Females | -1.90 (-2.81,-0.99) | < 0.001 |
| CNC LBP | ||
| Males | REF | |
| Females | -1.13 (-3.36, 1.10) | 0.320 |
| CC LBP | ||
| Males | REF | |
| Females | -5.21(-7.02,-3.40) | < 0.001 |
| No MBP or NSP | REF | |
| MBP or NSP | -3.04 (-3.93,-2.16) | < 0.001 |
| MBP and NSP | -4.56 (-5.76,-3.37) | < 0.001 |
| β (95% CI) | ||
| No LBP | REF | |
| Current Non-chronic LBP | -1.75 (-3.19,-0.31) | 0.017 |
| Current chronic LBP | -3.45 (-4.73,-2.17) | < 0.001 |
| Males | REF | |
| Females | -3.53 (-4.47,-2.58) | < 0.001 |
| No MBP or NSP | REF | |
| MBP or NSP | -2.83 (-3.93,-1.74) | < 0.001 |
| MBP and NSP | -4.40 (-5.87,-2.93) | < 0.001 |
1β coefficients represent the estimated mean difference between the reference group and the contrast group, adjusted for the other variables in the model
2 Significant gender × LBP group interaction (p = 0.003), therefore effects for LBP group reported separately by each gender, and
3 Significant gender × LBP group interaction (p = 0.003), therefore effects for female gender reported separately by each category of LBP group.